Showing 73–84 of 108 results

  • Mellitofix Trio 10/5/1000mg 30tablets

    Mellitofix Trio 10/5/1000mg 30tablets

    0 out of 5
    EGP486

    Medication Name: Mellitofix Trio 10/5/1000mg 30 Tablets Active Ingredients: Empagliflozin 10 mg Linagliptin 5 mg Metformin Hydrochloride 1000 mg Pharmacological Class:Combination of SGLT2 inhibitor, DPP-4 inhibitor, and biguanide antidiabetic agent Indication:Used for the management of type 2 diabetes mellitus in adults to improve glycemic control when diet, exercise, and monotherapy or dual therapy with these…

  • Mellitofix Trio 25/5/1000mg 30tablets

    Mellitofix Trio 25/5/1000mg 30tablets

    0 out of 5
    EGP486

    Medication Name: Mellitofix Trio 25/5/1000mg 30 Tablets Active Ingredients: Empagliflozin 25 mg Linagliptin 5 mg Metformin Hydrochloride 1000 mg Pharmacological Class:Combination of SGLT2 inhibitor, DPP-4 inhibitor, and biguanide antidiabetic agent Indication:Used for the treatment of type 2 diabetes mellitus in adults to improve glycemic control as an adjunct to diet and exercise when treatment with…

  • Metformin Eva 1000 XR 30 Tablets

    Metformin Eva 1000 XR 30 Tablets

    0 out of 5
    EGP70.50

    Medication Name: Metformin Eva 1000 XR 30 Tablets Active Ingredient:Metformin Hydrochloride 1000 mg (Extended Release) Pharmacological Class:Biguanide antidiabetic agent Indication:Used for the management of type 2 diabetes mellitus in adults, especially in overweight patients, to improve glycemic control when diet and exercise alone are insufficient. It may also be used in combination with other antidiabetic…

  • Mixtard 30 HM 100iu/ml 1 Vial 10ml

    Mixtard 30 HM 100iu/ml 1 Vial 10ml

    0 out of 5
    EGP130

    Medication Name: Mixtard 30 HM 100 IU/ml 1 Vial (10 ml) Active Ingredient:Human Insulin (Biphasic Isophane Insulin Injection 30/70) 30% soluble insulin (short-acting) 70% isophane insulin (intermediate-acting) Pharmacological Class:Antidiabetic (Human Insulin – intermediate and short-acting mixture) Indication:Used for the treatment of diabetes mellitus in patients who require insulin to maintain normal glucose levels. Dosage:The dose…

  • Mixtard 30 HM 100iu/ml 5 Penfills

    Mixtard 30 HM 100iu/ml 5 Penfills

    0 out of 5
    EGP338

    Medication Name: Mixtard 30 HM 100 IU/ml 5 Penfills Active Ingredient:Human Insulin (Biphasic Isophane Insulin Injection 30/70) 30% soluble insulin (short-acting) 70% isophane insulin (intermediate-acting) Pharmacological Class:Antidiabetic (Human Insulin – intermediate and short-acting mixture) Indication:Indicated for the treatment of diabetes mellitus in patients who require insulin to control blood glucose levels. Dosage:Dosage is individualized according…

  • Mounjaro 10mg\0.6ml 1 Kwikpen

    Mounjaro 10mg\0.6ml 1 Kwikpen

    0 out of 5
    EGP15,455

    Mounjaro 10 mg/0.6 ml (1 KwikPen) Active Ingredient: Tirzepatide 10 mg per 0.6 ml prefilled injection pen Therapeutic Class:Dual GIP and GLP-1 receptor agonist – Antidiabetic and weight management medication Indications: Type 2 diabetes mellitus in adults to improve blood glucose control: As monotherapy when metformin is not tolerated or contraindicated. Or in combination with…

  • Mounjaro 12.5mg\0.6ml 1 Kwikpen

    Mounjaro 12.5mg\0.6ml 1 Kwikpen

    0 out of 5
    EGP18,150

    Mounjaro 12.5 mg/0.6 ml (1 KwikPen) Active Ingredient: Tirzepatide 12.5 mg per 0.6 ml prefilled pen Therapeutic Class:Dual GIP and GLP-1 receptor agonist (antidiabetic and weight management agent) Indications: Type 2 diabetes mellitus in adults to improve blood glucose control: As monotherapy (if metformin is not suitable) Or in combination therapy with other antidiabetic medications…

  • Mounjaro 15mg\0.6ml 1 Kwikpen

    Mounjaro 15mg\0.6ml 1 Kwikpen

    0 out of 5
    EGP18,150

    Mounjaro 15 mg / 0.6 ml (1 KwikPen) Active Ingredient: Tirzepatide 15 mg per 0.6 ml – Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Pharmaceutical Form: Pre-filled injection pen (KwikPen) for subcutaneous use. Therapeutic Class: Antidiabetic and weight management medication. Indications: Type 2 diabetes mellitus in adults to improve glycemic control,…

  • Mounjaro 2.5mg\0.6ml 1 Kwikpen

    Mounjaro 2.5mg\0.6ml 1 Kwikpen

    0 out of 5
    EGP9,435

    Medication Name: Mounjaro 2.5mg/0.6ml 1 KwikPenActive Ingredient: Tirzepatide 2.5 mg per 0.6 ml injection Pharmacological Class: Dual GIP and GLP-1 receptor agonist (antidiabetic / weight-management agent) Indications: Type 2 diabetes mellitus (adjunct to diet and exercise) Sometimes used off-label for weight management in adults with obesity or overweight with related conditions Dosage Form: Prefilled pen…

  • Mounjaro 5mg\0.6ml 1 Kwikpen

    Mounjaro 5mg\0.6ml 1 Kwikpen

    0 out of 5
    EGP12,250

    Medication Name: Mounjaro 5mg/0.6ml 1 KwikPenActive Ingredient: Tirzepatide 5 mg per 0.6 ml injection Pharmacological Class: Dual GIP and GLP-1 receptor agonist (antidiabetic/weight management agent) Indications: Type 2 diabetes mellitus (as adjunct to diet and exercise) Sometimes prescribed off-label for weight reduction in adults with obesity or overweight with comorbidities Dosage Form: Prefilled pen (subcutaneous…

  • Mounjaro 7.5mg\0.6ml 1 Kwikpen

    Mounjaro 7.5mg\0.6ml 1 Kwikpen

    0 out of 5
    EGP15,455

    Mounjaro 7.5 mg/0.6 ml (1 KwikPen) Active Ingredient: Tirzepatide 7.5 mg per 0.6 ml prefilled pen Therapeutic Class:Dual GIP and GLP-1 receptor agonist (antidiabetic and weight management agent) Indications: Type 2 diabetes mellitus in adults to improve glycemic control: As monotherapy when metformin is not tolerated or contraindicated. In combination with other antidiabetic agents such…

  • Novomix 30 100iu/ml 5 Flexpens

    Novomix 30 100iu/ml 5 Flexpens

    0 out of 5
    EGP1,260

    Medication Name: Novomix 30 100 IU/ml 5 FlexPens Active Ingredients:Insulin Aspart 30% (rapid-acting component)Insulin Aspart Protamine Suspension 70% (intermediate-acting component) Pharmacological Class:Biphasic (premixed) insulin analog Indication:Used in adults and children with diabetes mellitus (type 1 or type 2) to improve glycemic control. It provides both rapid and intermediate insulin action to manage both postprandial and…

End of content

End of content